Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/UNITY-BIOTECHNOLOGY-INC-43214689/news/UNITY-Biotechnology-Doses-First-Patients-in-Phase-2-ASPIRE-Study-of-UBX1325-in-DME-45550589/?utm_source=whatsapp&utm_medium=social&utm_campaign=share